N
DRNA

Nuveen’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Nuveen’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-412,439
Closed -$8.31M – 3437
2021
Q3 		$8.31M Sell
412,439
-53,014
-11% -$1.46M ﹤0.01% 1903
2021
Q2 		$17.4M Buy
465,453
+135,843
+41% +$4.16M 0.01% 1483
2021
Q1 		$8.43M Sell
329,610
-42,064
-11% -$1.07M ﹤0.01% 1890
2020
Q4 		$8.19M Sell
371,674
-33,119
-8% -$729K ﹤0.01% 1829
2020
Q3 		$7.28M Buy
404,793
+45,431
+13% +$941K ﹤0.01% 1713
2020
Q2 		$9.13M Sell
359,362
-32,848
-8% -$708K ﹤0.01% 1541
2020
Q1 		$7.21M Buy
392,210
+868
+0.2% +$16.9K ﹤0.01% 1494
2019
Q4 		$8.62M Buy
391,342
+88,054
+29% +$1.77M ﹤0.01% 1673
2019
Q3 		$4.36M Buy
303,288
+49,732
+20% +$711K ﹤0.01% 2032
2019
Q2 		$3.99M Buy
+253,556
New +$3.45M ﹤0.01% 2103

Other funds holding DRNA

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Nuveen's DRNA Position: Q4 2021 in Review

Nuveen sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 412,439 shares — an estimated $8.31M sold.

Nuveen first reported a position in DRNA in Q2 2019 and held it in 10 quarters. The position peaked at $17.4M in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

  • Nuveen reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • Nuveen sold 412,439 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $8.31M.
  • Nuveen first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2019 and held it in 10 quarters.
  • Nuveen's Dicerna Pharmaceuticals, Inc. position peaked at $17.4M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Nuveen's 13F filing for Q4 2021, filed 14 Feb 2022.